Your browser doesn't support javascript.
loading
Development and characterization of a novel nanobody with SRMV neutralizing activity.
Sun, Miao; Wang, Changjiang; Luo, Huaye; Chen, Yanfei; Qu, Guanggang; Chen, Jian; Li, Ling; Zhang, Min; Xue, Qinghong.
Afiliação
  • Sun M; Department of Viral Biologics, China Institute of Veterinary Drug Control, Beijing, China.
  • Wang C; Shandong Binzhou Animal Science and Veterinary Medicine Academy, Binzhou, China.
  • Luo H; Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Science, Shanghai, China.
  • Chen Y; Department of Viral Biologics, China Institute of Veterinary Drug Control, Beijing, China.
  • Qu G; Shandong Binzhou Animal Science and Veterinary Medicine Academy, Binzhou, China.
  • Chen J; Department of Viral Biologics, China Institute of Veterinary Drug Control, Beijing, China.
  • Li L; Department of Viral Biologics, China Institute of Veterinary Drug Control, Beijing, China.
  • Zhang M; Tech-Bank Food Corporation Limited, Nanjing, China.
  • Xue Q; Department of Viral Biologics, China Institute of Veterinary Drug Control, Beijing, China. 18811026336@163.com.
Microb Cell Fact ; 23(1): 45, 2024 Feb 10.
Article em En | MEDLINE | ID: mdl-38341572
ABSTRACT
Peste des petits ruminants (PPR) is an acute, contact infectious disease caused by the small ruminant morbillivirus (SRMV), and its morbidity in goats and sheep can be up to 100% with significant mortality. Nanobody generated from camelid animals such as alpaca has attracted wide attention because of its unique advantages compared with conventional antibodies. The main objective of this study was to produce specific nanobodies against SRMV and identify its characteristics. To obtain the coding gene of SRMV-specific nanobodies, we first constructed an immune phage-displayed library from the VHH repertoire of alpaca that was immunized with SRMV-F and -H proteins. By using phage display technology, the target antigen-specific VHHs can be obtained after four consecutive rounds of biopanning. Results showed that the size of this VHH library was 2.26 × 1010 CFU/mL and the SRMV-F and -H specific phage particles were greatly enriched after four rounds of biopanning. The positive phage clones were selected and sequenced, and total of five independent different sequences of SRMV-specific nanobodies were identified. Subsequently, the DNA fragments of the five nanobodies were cloned into E. coli BL21(DE3), respectively, and three of them were successfully expressed and purified. Specificity and affinity towards inactivated SRMV of these purified nanobodies were then evaluated using the ELISA method. Results demonstrated that NbSRMV-1-1, NbSRMV-2-10, and NbSRMV-1-21 showed no cross-reactivity with other antigens, such as inactivated BTV, inactivated FMDV, His-tag labeled protein, and BSA. The ELISA titer of these three nanobodies against inactivated SRMV was up to 11000. However, only NbSRMV-1-21 displayed SRMV neutralizing activity at a maximum dilution of 14. The results indicate that the nanobodies against SRMV generated in this study could be useful in future applications. This study provided a novel antibody tool and laid a foundation for the treatment and detection of SRMV.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bacteriófagos / Camelídeos Americanos / Vírus da Peste dos Pequenos Ruminantes / Peste dos Pequenos Ruminantes / Anticorpos de Domínio Único Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Microb Cell Fact Assunto da revista: BIOTECNOLOGIA / MICROBIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Bacteriófagos / Camelídeos Americanos / Vírus da Peste dos Pequenos Ruminantes / Peste dos Pequenos Ruminantes / Anticorpos de Domínio Único Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Microb Cell Fact Assunto da revista: BIOTECNOLOGIA / MICROBIOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China